What does CUSIP 14888D208 represent in this 13F holders report?

CUSIP 14888D208 is the security identifier for CBIO - GYRE THERAPEUTICS INC COM - Stock used to aggregate holder disclosures.

How many institutions held CBIO - GYRE THERAPEUTICS INC COM - Stock in Q1 2017?

10 institutional investors reported CBIO - GYRE THERAPEUTICS INC COM - Stock for Q1 2017. Use the holders table for investor-level position and value details.

GYRE THERAPEUTICS INC COM - Stock (CBIO)

CUSIP: 14888D208

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / Stock
Total 13F shares: 182,568
Share change: +182,568
Total reported value: $1,721,000
Put/Call ratio: 55%
Price per share: $9.43
Number of holders: 10
Value change: +$1,721,000
Number of buys: 10

Quarterly Holders Quick Answers

What is CUSIP 14888D208?
CUSIP 14888D208 identifies CBIO - GYRE THERAPEUTICS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 14888D208:

Q2 2025 Q1 2025 Q4 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023

Institutional Holders of GYRE THERAPEUTICS INC COM - Stock (CBIO) as of Q1 2017

As of 31 Mar 2017, GYRE THERAPEUTICS INC COM - Stock (CBIO) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 182,568 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, NEA Management Company, LLC, UBS Group AG, SIMPLEX TRADING, LLC, VANGUARD GROUP INC, BlackRock Inc., BANK OF MONTREAL /CAN/, FNY Partners Fund LP, WELLS FARGO & COMPANY/MN, and Intellectus Partners, LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.